Comparison
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 vs Abdominal Cystic Lymphangioma C2930929
Clinical comparison between 46 XY Disorder OF Sex Development Due TO Isolated 17 20 Lyase Deficiency and Abdominal Cystic Lymphangioma for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
A rare condition involving deficiency of the 17,20-lyase enzyme needed for androgen synthesis. Affects 46,XY individuals and causes undervirilization. Managed with hormone therapy.
Abdominal Cystic Lymphangioma C2930929
A non-cancerous fluid-filled growth developing from lymphatic vessels in the abdomen. Usually found in children. Treatment may involve surgical removal or other interventions.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
0-0
Abdominal Cystic Lymphangioma C2930929
0-null
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
severe
Abdominal Cystic Lymphangioma C2930929
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
Chronic
Abdominal Cystic Lymphangioma C2930929
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
No
Abdominal Cystic Lymphangioma C2930929
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
reproductive
Abdominal Cystic Lymphangioma C2930929
congenital
Same/different system
Category
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
endocrine
Abdominal Cystic Lymphangioma C2930929
rare-disease
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-isolated-17-20-lyase-deficiency-C5681470 and abdominal-cystic-lymphangioma-C2930929 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 | Abdominal Cystic Lymphangioma C2930929 | Discriminating power |
|---|---|---|---|
| Genital appearance | Undervirilization in a 46,XY person may be present from birth. | External genitalia are not the defining feature. | High |
| Abdominal mass or swelling | Not a typical presenting feature based on the supplied description. | A fluid-filled abdominal lymphatic growth may cause a mass or swelling, often in children. | High |
| Hormone-related features | Androgen synthesis is impaired by 17,20-lyase deficiency. | No established endocrine mechanism is described. | High |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 when
46,XY infant or child with undervirilization
The source links this phenotype to isolated 17,20-lyase deficiency.
Moderate
Suspected disorder of androgen synthesis
The condition is endocrine and reproductive rather than a lymphatic mass.
Moderate
Need for long-term hormone management
The supplied description states management with hormone therapy.
Moderate
Choose Abdominal Cystic Lymphangioma C2930929 when
Child with a cystic abdominal lesion
Abdominal cystic lymphangioma is a fluid-filled lymphatic growth, usually found in children.
Moderate
Imaging suggests a benign lymphatic cyst
The source describes a non-cancerous growth from lymphatic vessels.
Moderate
Consideration of removal or other local intervention
Treatment may involve surgery or other interventions, not hormone replacement.
Moderate
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 | Abdominal Cystic Lymphangioma C2930929 | Interpretation |
|---|---|---|---|
| Karyotype or sex-chromosome assessment | Relevant to confirming a 46,XY context. | Not described as diagnostic. | A karyotype does not by itself prove enzyme deficiency or a lymphatic cyst. |
| Steroid or androgen evaluation | May support impaired androgen synthesis; exact cutoffs are not established here. | No characteristic hormone pattern is supplied. | Abnormal results require specialist interpretation and are not a diagnosis alone. |
| Abdominal imaging | No characteristic abdominal cystic finding is described. | May show a fluid-filled abdominal lesion. | Imaging appearance needs correlation with clinical findings and pathology when obtained. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
- Outcome
- A chronic severe endocrine condition whose individual outcome is not quantified here.
- Factors
- Degree of undervirilization, hormone management, and associated findings may matter.
Abdominal Cystic Lymphangioma C2930929
- Outcome
- Often a moderate chronic benign lesion, but course after intervention is not established here.
- Factors
- Size, location, symptoms, and response to removal or other treatment may matter.
Time frame: Both may be recognized early; long-term outcomes are not specified.
Accurate diagnosis, specialist follow-up, and avoidance of assumptions from sparse data.
Complications comparison
| Complication | Presentation |
|---|---|
| Undervirilization and puberty concerns | May affect genital development and later androgen-dependent features. Not a described feature. Extent varies; do not assume a uniform course. |
| Mass effect or local abdominal symptoms | Not established from the source. A cyst may enlarge or cause pressure-related symptoms. Symptom severity is not quantified here. |
| Treatment-related effects | Hormone therapy requires monitoring; doses are not specified. Surgery or other interventions may have procedure-related risks. Specific complication rates are not established in the supplied data. |
Patient education highlights
- HighDifferent conditions
One is a rare hormone-synthesis disorder; the other is a benign abdominal lymphatic cyst.
- HighSpecialist care
Endocrine or DSD care and surgical or pediatric assessment address different needs.
- MediumAvoid unsupported numbers
Prevalence, exact laboratory cutoffs, mortality, and doses are not established here.